Table 1.

STAT5A–/– and STAT5A+/+ donor bone marrow populations at baseline (non–5-FU) and after priming with 5-FU



STAT5A-/-,%

STAT5A+/+,%
MAC1+*
MAC1+

GR1-
GR1+
B220
GR1-
GR1+
B220
5-FU   82 ± 3   18 ± 3   42 ± 1   86 ± 5   14 ± 5   55 ± 1  
Non—5-FU
 
32 ± 4
 
68 ± 4
 
32 ± 4
 
32 ± 2
 
68 ± 4
 
33 ± 3
 


STAT5A-/-,%

STAT5A+/+,%
MAC1+*
MAC1+

GR1-
GR1+
B220
GR1-
GR1+
B220
5-FU   82 ± 3   18 ± 3   42 ± 1   86 ± 5   14 ± 5   55 ± 1  
Non—5-FU
 
32 ± 4
 
68 ± 4
 
32 ± 4
 
32 ± 2
 
68 ± 4
 
33 ± 3
 

Results expressed as percent ± SE; n = 3 for each STAT5A genotype.

*

Immature (MAC1+/GR1-) and mature (MAC1+/GR1+) myeloid cells are expressed as a percentage of total MAC1+ cells.

or Create an Account

Close Modal
Close Modal